Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis

por Gorouhi, F, Islami, F, Bahrami, H, Kamangar, F
Publicado 2008

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

por Mascaux, C, Iannino, N, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Noel, S, Lafitte, J-J, Sculier, J-P
Publicado 2005

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

por Kim, S T, Kang, W K, Kang, J H, Park, K W, Lee, J, Lee, S-H, Park, J O, Kim, K, Kim, W S, Jung, C W, Park, Y S, Im, Y-H, Park, K
Publicado 2005

Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study

por Serin, D, Verrill, M, Jones, A, Delozier, T, Coleman, R, Kreuser, E-D, Mross, K, Longerey, B, Brandely, M
Publicado 2005

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric c...

por Moehler, M, Eimermacher, A, Siebler, J, Höhler, T, Wein, A, Menges, M, Flieger, D, Junginger, T, Geer, T, Gracien, E, Galle, P R, Heike, M
Publicado 2005

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

por Dearnaley, D P, Fossa, S D, Kaye, S B, Cullen, M H, Harland, S J, Sokal, M P J, Graham, J D, Roberts, J T, Mead, G M, Williams, M V, Cook, P A, Stenning, S P
Publicado 2005

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

por Gowardhan, B, Douglas, D A, Mathers, M E, McKie, A B, McCracken, S R C, Robson, C N, Leung, H Y
Publicado 2005

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

por Ardavanis, A, Tryfonopoulos, D, Alexopoulos, A, Kandylis, C, Lainakis, G, Rigatos, G
Publicado 2005

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for ris...

por Jernström, H, Sandberg, T, Bågeman, E, Borg, Å, Olsson, H
Publicado 2005

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial...

por Atzpodien, J, Schmitt, E, Gertenbach, U, Fornara, P, Heynemann, H, Maskow, A, Ecke, M, Wöltjen, H H, Jentsch, H, Wieland, W, Wandert, T, Reitz, M
Publicado 2005

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer

por Yeh, K H, Lu, Y S, Hsu, C H, Lin, J F, Chao, H J, Huang, T C, Chung, C Y, Chang, C S, Yang, C H, Cheng, A L
Publicado 2005

Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour

por Dote, H, Toyooka, S, Tsukuda, K, Yano, M, Ota, T, Murakami, M, Naito, M, Toyota, M, Gazdar, A F, Shimizu, N
Publicado 2005

Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

por Panousis, C, Rayzman, V M, Johns, T G, Renner, C, Liu, Z, Cartwright, G, Lee, F-T, Wang, D, Gan, H, Cao, D, Kypridis, A, Smyth, F E, Brechbiel, M W, Burgess, A W, Old, L J, Scott, A M
Publicado 2005

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo

por Pukac, L, Kanakaraj, P, Humphreys, R, Alderson, R, Bloom, M, Sung, C, Riccobene, T, Johnson, R, Fiscella, M, Mahoney, A, Carrell, J, Boyd, E, Yao, X T, Zhang, L, Zhong, L, von Kerczek, A, Shepard, L, Vaughan, T, Edwards, B, Dobson, C, Salcedo, T, Albert, V
Publicado 2005

Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma

por Ahmed, N, Riley, C, Oliva, K, Rice, G, Quinn, M
Publicado 2005

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour

por Astuti, D, Latif, F, Wagner, K, Gentle, D, Cooper, W N, Catchpoole, D, Grundy, R, Ferguson-Smith, A C, Maher, E R
Publicado 2005

Altered expression of topoisomerase IIα contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation

por Asano, T, Nakamura, K, Fujii, H, Horichi, N, Ohmori, T, Hasegawa, K, Isoe, T, Adachi, M, Otake, N, Fukunaga, Y
Publicado 2005

Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori

por Williams, L, Jenkins, G J S, Doak, S H, Fowler, P, Parry, E M, Brown, T H, Griffiths, A P, Williams, J G, Parry, J M
Publicado 2005

Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

por Buckowitz, A, Knaebel, H-P, Benner, A, Bläker, H, Gebert, J, Kienle, P, von Knebel Doeberitz, M, Kloor, M
Publicado 2005

Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP

por Cummings, J, Ward, T H, LaCasse, E, Lefebvre, C, St-Jean, M, Durkin, J, Ranson, M, Dive, C
Publicado 2005